Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Beau Ances on amyloid biomarkers in Alzheimer’s

Beau Ances on amyloid biomarkers in Alzheimer’s

FromThe Lancet Neurology in conversation with


Beau Ances on amyloid biomarkers in Alzheimer’s

FromThe Lancet Neurology in conversation with

ratings:
Length:
12 minutes
Released:
Dec 12, 2022
Format:
Podcast episode

Description

Beau Ances (Washington University in St Louis, MO, USA) discusses recent research on amyloid biomarkers in people with genetic forms of Alzheimer’s disease; his Article is published in the January issue of The Lancet Neurology. 
Released:
Dec 12, 2022
Format:
Podcast episode

Titles in the series (100)

Our Editors and and the journal’s authors explore their research and its impact on people’s health, health care, and health policy in this regular podcast.